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Abstract  26 
Dengue encephalitis (DE) is characterized as unusual presentation of dengue infection. 27 
Despite the reports that DE accounts for only 1% to 5% of dengue cases, this disease tends to 28 
be increasingly reported to threaten global human health throughout dengue endemic areas 29 
particularly in Southeast Asia. The molecular information of clinically characterized, 30 
neurotropic dengue virus (DENV) in human beings is extremely scarce despite it playing an 31 
important role in deciphering the pathogenesis of dengue-related neurological cases. Here we 32 
report a case of DE caused by DENV3 genotype III in a male patient with atypical symptoms 33 
of DENV infection in Hai Phong, Vietnam in 2013. The virus isolated from the cerebrospinal 34 
fluid of this case-patient was closely related to DENV3 genotype III strains isolated from 35 
serum of two other patients, who manifested classical dengue in the same year and residing in 36 
the same area as the case-patient. It is noteworthy to mention that in 2013, DENV3 genotype 37 















1. Why this case is important 51 
Dengue virus (DENV) is a member of the family Flaviviridae consisting of 52 
neurotropic viruses such as Japanese encephalitis virus, West Nile virus, St Louis encephalitis 53 
virus and Murray Valley encephalitis virus. Unlike these pathogens, DENV rarely causes 54 
neurologic symptoms (1). The early evidence of central nervous system (CNS) manifestations 55 
associated with DENV infection was reported in several worldwide dengue outbreaks, 56 
predominantly in endemic countries of Southeast Asia (1-6). These unusual presentations 57 
have been classified as severe dengue cases (7) , however, the neuropathogenesis of DENV 58 
infection is still poorly understood (8). Previously, neurologic manifestations were considered 59 
as the consequences of an encephalopathy secondary to prolonged shock, hyponatraemia, 60 
hepatic failure or intracranial bleeding rather than encephalitis because of the failure to 61 
demonstrate the presence of DENV in the CNS (9, 10). Since the 1990s, the concept of 62 
DENV neurotropism was noticed and the number of reports on dengue patients with virus 63 
isolation from CSF or brain tissue has risen (10, 11). We hereby report a case of encephalitis 64 
caused by DENV3 in a male patient with atypical symptoms of DENV infection in Hai 65 
Phong, Vietnam. Virus isolation was achieved from CSF specimen. The complete envelope 66 
(E) sequence of CSF-derived DENV3 isolated from this patient was explored to define 67 
phylogenetic relationship with other DENV3 strains isolated from Hai Phong, Vietnam and 68 
from neighboring countries. We noted that DENV3 genotype III was seen for the first time in 69 
Vietnam in 2013. 70 
 71 
2. Case description 72 
A 25-year-old male, who worked as an accountant in Hai Phong, Vietnam, was 73 
admitted to Viet Tiep’s hospital on day 1 of the onset of illness due to high-grade fever and 74 
severe headache. There was no myalgia, joint pain, diarrhea, skin and mucosal bleeding. The 75 
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patient did not have any past medical records indicating of DENV infection prior to this 76 
event. On admission, general examination did not reveal any significant abnormalities. 77 
Neurological examination did not show any focal neurological deficits apart from neck 78 
stiffness. Laboratory tests showed normal range in hemogram with slight increase in C – 79 
reactive protein (Table 1). CSF analysis revealed 10 white blood cells (WBC)/mm3 but there 80 
was no information relating to protein, sugar and lactate (Table 1). A provisional diagnosis of 81 
suspected meningoencephalitis was made and the patient was given an empiric antibiotic 82 
treatment (Rocephin – the 3rd generation cephalosporin antibiotic) in view of the possibility 83 
of bacterial infection. Despite this treatment, his symptoms were not improved, therefore, he 84 
was transferred to the referral hospital on day 3 of disease onset. In this hospital, leukopenia 85 
was noted in the laboratory tests; CSF analysis revealed 8 WBC/mm3 and slight increase in 86 
protein concentration (Table 1). Treatment was continued with the 3rd generation of 87 
cephalosporin antibiotic (Ceftriaxon) and analgesic. Occasionally, the patient was prescribed 88 
with oral sedative (Seduxen) to control the irritation due to severe headache. On day 6 of 89 
disease onset, hemogram showed continuous leukopenia associated with mild 90 
thrombocytopenia and dengue serology (SD BIOLINE Dengue Duo kit) was positive for 91 
anti-dengue IgM and IgG antibodies. Additionally, the patient started to feel improvement 92 
from the symptoms of fever and headache simultaneous with the appearance of 93 
maculopapular rash. On day 9 of disease onset, hemogram indicated a normalization of 94 
leukocyte and platelet counts (Table 1). The patient was discharged after 9 days of 95 
hospitalization without any neurological sequelae. 96 
Following these results, a CSF specimen of this patient collected on day 1 of disease 97 
onset in Viet tiep’s hospital was retrospectively analyzed. In this CSF sample, although the 98 
presence of anti-dengue IgM antibodies was negative by the in-house ELISA test, the 99 
presence of DENV RNA was confirmed by reverse transcriptase polymerase chain reaction 100 
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(RT-PCR) and DENV3 was successfully isolated (Table 2). RNA sequence of this virus strain 101 
was read by Ion Proton and 3100 Avant genetic analyzer (Life Technologies). Phylogenetic 102 
analysis was conducted using the envelop protein coding region sequence with the two other 103 
serum-derived DENV3 strains isolated in Hai Phong, Vietnam in 2013 and with other 104 
DENV3 strains worldwide. 105 
 106 
3. Other similar and contrasting cases in literature 107 
Following the earliest evidence of CNS involvement associated with DENV infection 108 
since 18th century (12), neurological cases due to DENV3 have been increasingly reported in 109 
recent years worldwide (1, 5, 10, 13, 14). In the southern part of Vietnam, there was one 110 
study that described the phylogenetic relationship between CSF-derived DENV2 and serum-111 
derived DENV2 from the same DE patient (14), however, there are no published data on 112 
DENV3 genotype III infecting a patient with neurological manifestation. 113 
 114 
4. Discussion  115 
Dengue encephalitis has been noticed as an unusual presentation with the prevalence 116 
being estimated to occur in 1% to 5% of dengue cases (8). Neurologic manifestations caused 117 
by DENV can occur in a patient at the age of few months to 79 years and more frequently in 118 
children (8). The median time for onset of CNS symptoms was reported to be 3 to 7 days 119 
from the onset of fever (1, 4). Interestingly, Soares et al (2006) reported the existence of CNS 120 
involvement for longer period ranging between 4 to 30 days with a median time of 12 days 121 
after the onset of the fever among 13 patients aged 11 to 79 years (15). Surprisingly, the 122 
presented case showed CNS symptoms on day 1 of the onset of fever. 123 
In comparison to other dengue serotypes, DENV2 and DENV3 tend to have the highest 124 
propensity to neurological complications whether in primary or secondary infections (1, 4). 125 
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Despite encephalitis being recognized as the most common presentation among patients 126 
suffering neurological manifestations due to DENV infection, only 50% of these patients 127 
present the typical features of DENV infection (8); thus the existence of underestimated 128 
cases. Our patient from the beginning did not have any typical symptoms of dengue until the 129 
hemogram from the referral hospital suggested DENV infection. However, CSF analysis 130 
indicated viral infection at the early timing of disease course. Retrospective analysis of a CSF 131 
specimen drawn on day 1 of fever onset was negative for anti-dengue IgM antibody by in-132 
house ELISA test. This result is acceptable because in serum specimens, IgM antibodies are 133 
detectable by day 3-5 from the onset of illness in 50% of patients, increasing to 80% by day 5 134 
and 99% by day 10 during primary infection and significantly lower in secondary infection 135 
(7). Furthermore, data on ELISA test for dengue specific IgM antibodies revealed 46% 136 
sensitivity in CSF of patients with neurological disorders, however, the absence of these 137 
antibodies does not exclude dengue as the causative agent of CNS abnormalities (15). The 138 
day for collecting CSF sample from this patient in the 1st hospital, i.e. day 1 from the onset of 139 
the disease was too early to detect anti-dengue IgM antibodies in serum or in CSF, but it was 140 
proper timing for virus isolation.  141 
To isolate the virus, CSF specimen (10ul) was inoculated onto C6/36 mosquito cells 142 
and Vero cells (African green monkey kidney). Cells were observed daily for cytopathic 143 
effect (CPE) for seven days, RNA was extracted from culture fluid on day seven by using 144 
QIAamp Viral RNA mini kit (QIAGEN) and the presence of DENV3 RNA was confirmed by 145 
RT-PCR (Table 2) (16). The complete envelope nucleotide sequences of this isolate 146 
(accession nos. KP893717) and the two serum-derived DENV3 isolates from different 147 
patients with classical dengue fever in Hai Phong, Vietnam (accession nos. KP893718 and 148 
KP893719) were determined and deposited in Genbank. Nucleotides sequences were aligned 149 
by using MAFFT version 7.215 (17). The substitution models were selected by jmodeltest-150 
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2.1.7 (18) and GTR+I+G was used as the model. Phylogenetic tree was constructed by 151 
FigTree software, version 1.4.0. The envelope sequence of the three strains did not show any 152 
difference in nucleotide and amino acid substitutions. However, the ongoing full genome 153 
analysis showed Leu-3029-Phe and Thr-4077-Ile mutations in non-structural regions 1 and 154 
2A (NS1& NS2A) sequences respectively in CSF derived DENV3 strain (data not shown). 155 
Phylogenetic analysis showed the close relationship between this CSF-derived 156 
DENV3 and the two serum-derived DENV3 strains and all of them were isolated from 157 
different patients in Hai phong, Vietnam in 2013 and were determined to belong to genotype 158 
III (Figure 1). Previously, genotype II had been circulating in Vietnam (Figure 1). DENV3 159 
genotype III was reported to be continuously circulating in the Indian subcontinent since the 160 
1960s (19). Since 2005, this genotype III of DENV3 was increasingly found in Bhutan, 161 
Thailand, Laos, Cambodia, Pakistan, China, Senegal and Côte d’Ivoire (19-22) (Figure 1). To 162 
our knowledge, this is the first report describing the emergence of DENV3 genotype III in 163 
Vietnam in 2013.  164 
 In conclusion, dengue encephalitis is a rarely reported infection, however, its 165 
detection tends to increase the threat to global human health. Despite the unusual 166 
manifestations and challenges in diagnosis, DE should be investigated further in all patients 167 
with encephalitis regardless of the absence of classical dengue features. 168 
 169 
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Figure 1: ML-phylogenetic tree based on the envelope gene sequence of DENV3 isolates. The 
envelope sequence of DENV3 (CSF11098) isolated from the CSF of our case-patient in Hai 
Phong,Vietnam in 2013 was compared with those of DENV3 (5228 NGS and 5468 NGS) 
isolated from serum samples of other patients in the same place and in the same year. The strain 
names of these three DENV3 isolates were enclosed in red square. This fragment of CSF derived 
DENV3 was also compared with others homologous sequences of DENV3 in GenBank database 
from different geographical regions. Bootstrap values over 800 > of 1000 repeats are shown at 
the nodes. Labels of strains conform to the following format: (GenBank accession nos)_(Strain 
name)_(Country-region)_(Year of isolation). 
 
Table 1: Summary of laboratory analysis during admission 
Hospital Viet tiep’s hospital Referral hospital 
Day of onset 1 3 6 9 
Hemogram  
– WBC (x103/ul) 
– Hb (g/dl) 
– Hct (%) 





















CRP (mg/l)  12 0.79 ND ND 
AST (U/l) 40 55 ND ND 
ALT (U/l) 28 50 ND ND 
Dengue serology test 
– Anti – dengue IgM antibody 















– Protein (g/l) 
– Glucose (mmol/l) 
– Gram staining 

























WBC: white blood cells; Hb: Hemoglobin; Hct: Hematocrit; PLT: platelet; CRP: C-reactive 
protein (normal range: <0.5mg/dl); AST: aspartate transaminase (normal range: <37 U/l); ALT: 
alanine transaminase (normal range: <41 U/l); CSF: cerebral spinal fluid; Pos: positive; Neg: 
negative; ND: not done 
(*): 60% polymorphs and 40% lymphocytes 
 
Table 2: Primers use for RT-PCR and amplification of DENV3 envelope gene.  
Primer name Reaction sense Sequence (5’-3’) 
Random primer RT-PCR -  
VNR primer RT-PCR - AGAACCTGTTGATTCAACAGCACCATTCCA 
DENV-consensus PCR F TCAATATGCTGAAACGCGCGAGAAACCG 
DENV-consensus PCR R TTGCACCAACAGTCAATGTCTTCAGGTTC 
DENV-3-specific PCR F GTGCTTACACAGCCCTATTT 
DENV-3-specific PCR R TCCATTCTCCCAAGCGCCTG 
RT-PCR: reverse transcriptase-polymerase chain reaction; F: forward; R: reverse; DENV: 
dengue virus. 
 
